AMN

SEC source: 0001209191-19-025400 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,388

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-025398 · doc4.xml · derivative · entry 3

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025398 · doc4.xml · derivative · entry 2

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025398 · doc4.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-025395 · doc4.xml · derivative · entry 1

STERN ANDREW M · CIK 0001158585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025391 · doc4.xml · derivative · entry 3

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025391 · doc4.xml · derivative · entry 2

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025391 · doc4.xml · nonDerivative · entry 1

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-025385 · doc4.xml · derivative · entry 3

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025385 · doc4.xml · derivative · entry 2

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,608 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on July 27, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (1608) vested on April 17, 2019.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025385 · doc4.xml · nonDerivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,608

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-025371 · doc4.xml · derivative · entry 3

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025371 · doc4.xml · derivative · entry 2

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025371 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-025368 · doc4.xml · derivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Underlying: Common Stock · 2,907 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs were granted on April 17, 2019 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2020 Annual Meeting of Shareholders.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025368 · doc4.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs were granted on April 18, 2018 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2019 Annual Meeting of Shareholders. The Company's 2019 Annual Meeting of Shareholders was held on April 17, 2019. Accordingly, the number of RSUs identified in this row (2,153) vested on April 17, 2019.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-025368 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-023980 · doc4.xml · derivative · entry 3

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,224 shares

Expires 2019-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The SSARs set forth in this row were granted on April 9, 2009 pursuant to the AMN Healthcare Equity Plan and vested on the one year anniversary of the grant date.

SEC source: 0001209191-19-023980 · doc4.xml · nonDerivative · entry 2

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,235

F1 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. The number set forth in this row represents the difference between the number of SSARs exercised (8,224) and the number of shares of Stock issued as a result of the exercise (7,213).

SEC source: 0001209191-19-023980 · doc4.xml · nonDerivative · entry 1

Weaver Paul E · CIK 0001363498 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,246

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-020971 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,184

Underlying: Common Stock · 58,185 shares

Expires 2020-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: The exercise of derivative securities reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · derivative.exercise_date: The SSARs set forth in this row were granted on February 2, 2010 pursuant to the AMN Healthcare Equity Plan and vested in three equal installments on the first, second and third anniversary of the grant date.

SEC source: 0001209191-19-020971 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,686

F2 · kind: The sale of 28,746 shares of Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in this row represents a weighted average price of $48.048 per share. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-020971 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,432

F1 · shares: A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. The number set forth in this row represents the difference between the number of SSARs exercised (58,185), and the number of shares of Stock issued as a result of the exercise (28,746).

SEC source: 0001209191-19-020971 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,871

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-025402 · doc4.xml · nonDerivative · entry 1

JOHNS MICHAEL M E · CIK 0001221096 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,659

F1 · kind: The reporting person transferred 2,759 shares of AMN Common Stock as a gift to charity.

SEC source: 0001209191-19-012090 · doc4.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,687

Underlying: Common Stock · 6,742 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs identified in this row were granted on December 19,2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2018 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2019 fiscal year.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-012090 · doc4.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,872

Underlying: Common Stock · 10,172 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The RSUs identified in this row were granted on December 5, 2016 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,686

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,338

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,596

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,426

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-012090 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,615

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2018 for the one-year period beginning on January 1, 2018 and ended December 31, 2018. As a result, 77.50% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-012036 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,216

Underlying: Common Stock · 1,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-012036 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,325

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-012036 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,758

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-012036 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,504

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-012036 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,746

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2018 for the one-year period beginning on January 1, 2018 and ended December 31, 2018. As a result, 77.50% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-011998 · doc4.xml · derivative · entry 5

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,077

Underlying: Common Stock · 2,140 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-011998 · doc4.xml · nonDerivative · entry 4

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,256

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-011998 · doc4.xml · nonDerivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,317

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-011998 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,177

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-011998 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,850

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2018 for the one-year period beginning on January 1, 2018 and ended December 31, 2018. As a result, 77.50% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-011979 · doc4.xml · derivative · entry 5

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,077

Underlying: Common Stock · 2,140 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2017 and vest on the third anniversary of the grant date, provided, however, the RSUs shall vest on an accelerated basis thirteen months after the grant date, in the incremental amount of 33%, should the Company achieve or exceed a certain specified earnings before interest, taxes, depreciation and amortization (EBITDA) target for the 2017 fiscal year, and on the second anniversary of the grant date, in the amount of 34%, should the Company achieve or exceed the specified EBITDA target for the 2018 fiscal year.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-19-011979 · doc4.xml · nonDerivative · entry 4

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,328

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-011979 · doc4.xml · nonDerivative · entry 3

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,170

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-19-011979 · doc4.xml · nonDerivative · entry 2

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,030

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-19-011979 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,151

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2018 for the one-year period beginning on January 1, 2018 and ended December 31, 2018. As a result, 77.50% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-19-006905 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,458

F1 · kind: The sale of 7,500 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported represents a weighted average price of $65.0144 per share. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-003379 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,759

F1 · kind: The sale of 12,960 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $59.4284 per share. These shares were sold in multiple transactions at prices ranging from $59.09 to $60.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.